Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Mechanistic consequences of ELFN1 pathogenic variants in neurodevelopmental disease

FY 2023-24

Summary
Neuronal communication is a complex process orchestrated by many synaptic proteins: yet the underlying mechanisms remain poorly understood. My research explores how synaptic dysregulation contributes to the etiology of neurodevelopmental diseases (NDDs) with a focus on G-protein coupled receptors (GPCRs): the therapeutic target of 35% of FDA-approved drugs. Excitingly, we recently discovered prominent GPCR drug targets – presynaptic metabotropic glutamate receptors (mGluRs) – are under trans-synaptic modulation by the postsynaptic adhesion molecule extracellular leucine rich fibronectin type 3 domain 1 (ELFN1): representing an entirely new concept in synaptic neurobiology that critically alters our understanding of neuronal communication and GPCR drug design strategies. Furthermore, we now possess significant preliminary data suggesting ELFN1 may additionally act as a postsynaptic signalling molecule independently of mGluRs. Most importantly, multiple human pathogenic ELFN1 variants (vELFN1s) have now been identified in various NDDs across both male and female patients, and based on the diverse locations of these genetic variations in both the extracellular and intracellular domains of ELFN1, we hypothesize these vELFN1s will have both mGluR-dependent presynaptic effects and mGluR-independent postsynaptic effects. This study seeks to elucidate the molecular consequence of vELFN1s on both pre- and postsynaptic functions to understand the aetiologies of NDD patients harbouring vELFN1s and guide potential pharmacological treatment strategies. In doing so, we will develop a new synaptic model utilizing male and female induced pluripotent stem cells (iPSCs) mimicking NDD patients and advance the characterization of a novel yet fundamental mechanism in synaptic communication.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
505993
Name
Dhaliwal Simran K
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanistic consequences of ELFN1 pathogenic variants in neurodevelopmental disease
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Extracellular Leucine Rich Fibronectin Type Iii Domain 1; G-Protein Coupled Receptors; Metabotropic Glutamate Receptors; Molecular Biology; Neurodevelopmental Diseases; Neuropharmacology; Pathogenic Mutations; Pharmaceutical Therapies; Synaptic Adhesion Molecules; Trans-Synaptic Signalling
Abstract
Neuronal communication is a complex process orchestrated by many synaptic proteins: yet the underlying mechanisms remain poorly understood. My research explores how synaptic dysregulation contributes to the etiology of neurodevelopmental diseases (NDDs) with a focus on G-protein coupled receptors (GPCRs): the therapeutic target of 35% of FDA-approved drugs. Excitingly, we recently discovered prominent GPCR drug targets – presynaptic metabotropic glutamate receptors (mGluRs) – are under trans-synaptic modulation by the postsynaptic adhesion molecule extracellular leucine rich fibronectin type 3 domain 1 (ELFN1): representing an entirely new concept in synaptic neurobiology that critically alters our understanding of neuronal communication and GPCR drug design strategies. Furthermore, we now possess significant preliminary data suggesting ELFN1 may additionally act as a postsynaptic signalling molecule independently of mGluRs. Most importantly, multiple human pathogenic ELFN1 variants (vELFN1s) have now been identified in various NDDs across both male and female patients, and based on the diverse locations of these genetic variations in both the extracellular and intracellular domains of ELFN1, we hypothesize these vELFN1s will have both mGluR-dependent presynaptic effects and mGluR-independent postsynaptic effects. This study seeks to elucidate the molecular consequence of vELFN1s on both pre- and postsynaptic functions to understand the aetiologies of NDD patients harbouring vELFN1s and guide potential pharmacological treatment strategies. In doing so, we will develop a new synaptic model utilizing male and female induced pluripotent stem cells (iPSCs) mimicking NDD patients and advance the characterization of a novel yet fundamental mechanism in synaptic communication.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dhaliwal, Simran K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~